Home › Categories › Health & Wellness› Dostupné Online

Dostupné Online.pdf

covid-19-vaccines-safety-update-20-january-2022_en.pdf

🔗 Source: ema.europa.eu

📊 Size: 251 KB

👤 Author: European Medicines gency

⬇️ Downloads: 205

Summary

The European Medicines Agency (EMA) continuously monitors the safety of authorized COVID-19 vaccines and provides regular updates. As of January 2022, the benefits of all currently authorized COVID-19 vaccines continue to outweigh their side effects. Key updates include:

Comirnaty and Spikevax: ongoing assessment of potential link to capillary leak syndrome, no sign of adverse outcomes in pregnancy.
COVID-19 Vaccine Janssen: updated product information to include transverse myelitis and thrombosis with thrombocytopenia syndrome as side effects.
Spikevax: updated product information to include paraesthesia as a rare side effect.
Nuvaxovid: no new information as it has not yet been used in the EU/EEA.
* Vaxzevria and Jcovden (previously COVID-19 Vaccine Janssen): withdrawn from the EU market for commercial reasons, but this does not affect the safety update information.

Download File

Description

The European Medicines Agency (EMA) continuously monitors the safety of authorized COVID-19 vaccines and provides regular updates.

Technical Information

File Format: PDF
File Size: 251 KB
Pages: 10
Language: EN
Author: European Medicines gency
Total Downloads: 205
Last Updated: 1 week ago

Document Overview

This PDF document about Dostupné online provides comprehensive information and guidance. Whether you're a beginner or advanced user, this resource offers valuable insights into Dostupné online.